Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Daiichi Sankyo
Related studies linked through entity extraction aliases.
Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prasugrel Versus Placebo in Adult Sickle Cell Disease
- Status
- COMPLETED
- Phase
- PHASE2
Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) Scale
- Status
- COMPLETED
- Phase
- PHASE4
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
- Status
- COMPLETED
- Phase
- PHASE4
Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome
- Status
- COMPLETED
- Phase
- N/A
Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
- Status
- TERMINATED
- Phase
- PHASE3
ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
- Status
- COMPLETED
- Phase
- PHASE2
A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation Study
- Status
- COMPLETED
- Phase
- PHASE4
ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prasugrel/Clopidogrel Maintenance Dose Washout Study
- Status
- COMPLETED
- Phase
- PHASE4
Safety Study of PLX108-01 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
TAXUS Libertē Post Approval Study
- Status
- COMPLETED
- Phase
- N/A
Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3